Laden…
3-(2-piperidin-4-ylethyl)-1H-indole
Indalpine is a selective serotonin reuptake inhibitor (SSRI) developed for the treatment of depression. It works by inhibiting the serotonin transporter, which increases serotonin concentration in the synaptic cleft. However, due to safety concerns, Indalpine has been withdrawn from the market. The substance exhibits typical SSRI properties with a moderate side effect profile.
Class
SSRI
Pharmacological context
Mechanism
SERT inhibitor
Short read on known pharmacology
Interactions
No curated pairs visible
Curated visible combinations
Risk theme
Interpret risks carefully
Condensed from structured notes
Translation in progress
The German version has more complete content. This English page is being expanded; safety-critical risk and interaction sections may still appear while translation continues.
Receptor Targets
Mechanism of Action
Indalpine acts through the following pharmacological mechanisms:
Designations
IUPAC: 3-[2-(4-piperidyl)ethyl]-1H-indole
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Receptor Profile
Der Serotonintransporter (SERT/5-HTT) ist ein Natrium-abhängiger Monoamintransporter, der Serotonin aus dem synaptischen Spalt zurück in die präsynaptische Zelle transportiert. Er ist das primäre Ziel von SSRI und MDMA.
Substance Fingerprint
Pharmacological profile based on receptor binding, mechanism of action, and substance class. Limited data — interpret profile with caution.
Synapedia Evidence
Effects & Pharmacology translation in progress
English prose is being expanded. The German version currently has more detail.
Reported range 20–40 mg
Oral
| Tier | Dosage |
|---|---|
| Light | 10–20 mg |
| Reported | 20–40 mg |
| Strong | 40–60 mg |
Oral
Onset
1–2 weeks
Peak
4–6 weeks
Avoid uncertain dosage claims and do not infer numbers when data is unclear.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks
Summary
Mögliche Nebenwirkungen und Wechselwirkungen mit anderen Medikamenten.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Interaction details from the knowledge layer are still being translated.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.